Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Assets: 2020-2022

Historic Non-Current Assets for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $1.8 million.

  • Terns Pharmaceuticals' Non-Current Assets fell 39.87% to $1.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.2 million, marking a year-over-year decrease of 39.87%. This contributed to the annual value of $1.8 million for FY2022, which is 61.49% up from last year.
  • According to the latest figures from FY2022, Terns Pharmaceuticals' Non-Current Assets is $1.8 million, which was up 61.49% from $1.1 million recorded in FY2021.
  • Terns Pharmaceuticals' Non-Current Assets' 5-year high stood at $1.8 million during FY2022, with a 5-year trough of $1.1 million in FY2021.
  • Its 3-year average for Non-Current Assets is $1.5 million, with a median of $1.4 million in 2020.
  • Its Non-Current Assets has fluctuated over the past 5 years, first declined by 19.77% in 2021, then spiked by 61.49% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Non-Current Assets (Yearly) stood at $1.4 million in 2020, then declined by 19.77% to $1.1 million in 2021, then spiked by 61.49% to $1.8 million in 2022.